Coloplast Research Development from 2010 to 2026
| CBHD Stock | EUR 65.08 0.28 0.43% |
Research Development | First Reported 2017-03-31 | Previous Quarter 239 M | Current Value 247 M | Quarterly Volatility 31.1 M |
Check Coloplast financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Coloplast's main balance sheet or income statement drivers, such as Interest Expense of 960 M, Selling General Administrative of 6.8 B or Total Revenue of 20.3 B, as well as many indicators such as . Coloplast financial statements analysis is a perfect complement when working with Coloplast Valuation or Volatility modules.
Coloplast | Research Development |
The Research Development trend for Coloplast AS offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Coloplast is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Coloplast's Research Development Growth Pattern
Below is the plot of the Research Development of Coloplast AS over the last few years. It is Coloplast's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Coloplast's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Coloplast Research Development Regression Statistics
| Arithmetic Mean | 660,591,176 | |
| Geometric Mean | 625,567,245 | |
| Coefficient Of Variation | 32.89 | |
| Mean Deviation | 183,497,578 | |
| Median | 692,000,000 | |
| Standard Deviation | 217,272,621 | |
| Sample Variance | 47207.4T | |
| Range | 660M | |
| R-Value | 0.93 | |
| Mean Square Error | 6607.9T | |
| R-Squared | 0.87 | |
| Slope | 40,104,044 | |
| Total Sum of Squares | 755318.3T |
Coloplast Research Development History
About Coloplast Financial Statements
Coloplast stakeholders use historical fundamental indicators, such as Coloplast's Research Development, to determine how well the company is positioned to perform in the future. Although Coloplast investors may analyze each financial statement separately, they are all interrelated. For example, changes in Coloplast's assets and liabilities are reflected in the revenues and expenses on Coloplast's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Coloplast AS. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 1 B | 736.1 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Coloplast Stock
Coloplast financial ratios help investors to determine whether Coloplast Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast security.